Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Samuel JK Abraham"'
Autor:
Nobunao Ikewaki, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Suryaprakash Vaddi, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
Publikováno v:
Clinical Immunology Communications, Vol 6, Iss , Pp 31-32 (2024)
Externí odkaz:
https://doaj.org/article/44f5c68d781b4f8b9afdb7dea9c0512e
Autor:
Nobunao Ikewaki, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Suryaprakash Vaddi, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
Publikováno v:
Clinical Immunology Communications, Vol 1, Iss , Pp 29-34 (2021)
The beneficial immunomodulation effects of a biological response modifier glucan (BRMG) produced by two strains of Aureobasidium pullulans, AFO-202 and N-163, have already been reported. Herein, we compared their efficacy on immune-inflammatory param
Externí odkaz:
https://doaj.org/article/69e105b6050f4bdda3ec62937fa195d2
Autor:
Nobunao Ikewaki, Masaru Iwasaki, Gene Kurosawa, Kosagi-Sharaf Rao, Johant Lakey-Beitia, Senthilkumar Preethy, Samuel JK Abraham
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 8, Pp 2808-2813 (2021)
Conventional vaccines to combat COVID-19 through different approaches are at various stages of development. The complexity of COVID-19 such as the potential mutations of the virus leading to antigenic drift and the uncertainty on the duration of the
Externí odkaz:
https://doaj.org/article/0478231d12be4362a48404c124b550a2
Autor:
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Ramesh Shankar Kandaswamy, Mangaleswaran Balamurugan, Nobunao Ikewaki, Tohru Sonoda, Gene Kurosawa, Masaru Iwasaki, Senthilkumar Preethy, Samuel JK Abraham
Publikováno v:
Brain and Behavior, Vol 12, Iss 9, Pp n/a-n/a (2022)
Abstract Introduction Poor sleep quality is a major problem in patients with autism spectrum disorder (ASD), and is attributed to low melatonin levels. Melatonin supplementation is recommended; however, its effectiveness varies. β‐Glucans have pre
Externí odkaz:
https://doaj.org/article/a3dd354d70684f05aa1f22dda11962e5
Autor:
Tohru Sonoda, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Senthilkumar Preethy, Samuel JK Abraham
Publikováno v:
BMJ Neurology Open, Vol 4, Iss 1 (2022)
Background Autism spectrum disorders (ASDs) are a wide range of behavioural disabilities for which there are no definite interventional modalities available. Remedial therapies remain the only option but with varying outcomes. We have evaluated the C
Externí odkaz:
https://doaj.org/article/c629b182d40d4508a5c74e31e974291a
Autor:
Shojiro Katoh, Atsuki Fujimaru, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK. Abraham
Publikováno v:
Regenerative Therapy, Vol 14, Iss , Pp 234-237 (2020)
Autologous chondrocytes in vitro expanded, are used as tools of regenerative therapies for cartilage injuries. However, inability to maintain the hyaline phenotype both in vitro and post in vivo transplantation, remains one of the major hurdles for l
Externí odkaz:
https://doaj.org/article/9267a62f2fa74aca86f605028443eb29
Autor:
Vidyasagar Devaprasad Dedeepiya, Chockanathan Vetrievel, Nobunao Ikewaki, Koji Ichiyama, Naoki Yamamoto, Hiroto Kawashima, Sudhakar S Bharatidasan, Subramaniam Srinivasan, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
IntroductionMultiple Sclerosis (MS) is a debilitating neurodegenerative disease in which demyelination due to auto-inflammation is considered to be the underlying pathogenesis, though the exact etiology is not known. Most of the management strategies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d71f228e483fd77cdb430088d311af3
https://doi.org/10.1101/2023.05.14.23289953
https://doi.org/10.1101/2023.05.14.23289953
Autor:
Kadalraja Raghavan, Thanasekar Sivakumar, Sudhakar S Bharatidasan, Subramaniam Srinivasan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
Duchenne muscular dystrophy (DMD) is a debilitating genetic disease that causes gradual muscle weakening and early mortality. After a 45-day clinical pilot study and a pre-clinical study in mdx mice demonstrating safety and efficacy, and anti-fibroti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::586fe9f56f99a45f514950424d67d478
https://doi.org/10.1101/2023.04.29.23289260
https://doi.org/10.1101/2023.04.29.23289260
Autor:
Chockanathan Vetrievel, Allimuthu Nithyanandam, Subramaniam Srinivasan, Sudhakar S Bharatidasan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
The aetiology of Parkinson’s disease (PD) has been linked to the aggregation and spread of misfolded alpha-synuclein via the gut-brain axis. We previously reported the effects of a biological response modifier, beta-glucan, produced by the AFO-202
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1694c074d1a6cabac1f6ebb9fdd39a9d
https://doi.org/10.1101/2023.04.14.23288571
https://doi.org/10.1101/2023.04.14.23288571
Autor:
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Naoki Yamamoto, Nobunao Ikewaki, Masaru Iwasaki, Ashwamed Dinassing, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
ObjectiveDuchenne muscular dystrophy (DMD) is an X-linked neuromuscular disorder that leads to increasing muscle weakening and early death. Steroids, the standard treatment of choice in slowing down disease progression, are plagued with adverse effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d6866d1e2c1dce41286d1a8c47f0683
https://doi.org/10.1101/2022.12.09.22283273
https://doi.org/10.1101/2022.12.09.22283273